BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32992126)

  • 1. Effects of telmisartan on proteinuria and systolic blood pressure in dogs with chronic kidney disease.
    Miyagawa Y; Akabane R; Sakatani A; Ogawa M; Nagakawa M; Miyakawa H; Takemura N
    Res Vet Sci; 2020 Dec; 133():150-156. PubMed ID: 32992126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double-masked, randomized clinical trial.
    Lourenço BN; Coleman AE; Brown SA; Schmiedt CW; Parkanzky MC; Creevy KE
    J Vet Intern Med; 2020 Nov; 34(6):2478-2496. PubMed ID: 33165969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the progression of non-azotemic proteinuric chronic kidney disease in dogs.
    Miyakawa H; Ogawa M; Sakatani A; Akabane R; Miyagawa Y; Takemura N
    Res Vet Sci; 2021 Sep; 138():11-18. PubMed ID: 34090202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril.
    Cortadellas O; Talavera J; Fernández del Palacio MJ
    J Vet Intern Med; 2014; 28(1):30-7. PubMed ID: 24372810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of proteinuria in dogs with telmisartan: A retrospective study.
    Lecavalier J; Fifle L; Javard R
    J Vet Intern Med; 2021 Jul; 35(4):1810-1818. PubMed ID: 33969924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of telmisartan, angiotensin-converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs.
    Fowler BL; Stefanovski D; Hess RS; McGonigle K
    J Vet Intern Med; 2021 May; 35(3):1231-1237. PubMed ID: 33769606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.
    Rysavá R; Tesar V; Merta M;
    Blood Press Monit; 2005 Aug; 10(4):207-13. PubMed ID: 16077267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis of albuminuria in canine chronic kidney disease.
    Paukner K; Filipejova Z; Mareš J; Vávra M; Rehakova K; Proks P; Gabriel V; Crha M
    Vet Med Sci; 2024 Mar; 10(2):e1403. PubMed ID: 38419297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease.
    Ames MK; Vaden SL; Atkins CE; Palerme JS; Langston CE; Grauer GF; Shropshire S; Bove C; Webb T
    J Vet Intern Med; 2022 Nov; 36(6):2088-2097. PubMed ID: 36350258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease.
    Rossi G; Giordano A; Breda S; Lisi C; Roura X; Zatelli A; Paltrinieri S
    Vet J; 2013 Oct; 198(1):109-15. PubMed ID: 23899407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of dietary supplementation with amino acids in dogs with proteinuric chronic kidney disease.
    Zatelli A; D'Ippolito P; Roura X; Zini E
    Can Vet J; 2017 Dec; 58(12):1287-1293. PubMed ID: 29203938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases.
    Wehner A; Hartmann K; Hirschberger J
    Vet Rec; 2008 Feb; 162(5):141-7. PubMed ID: 18245745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors.
    Fulton EA; McBrearty AR; Shaw DJ; Ridyard AE
    J Vet Intern Med; 2023; 37(6):2188-2199. PubMed ID: 37815154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients.
    Cupisti A; Rizza GM; D'Alessandro C; Morelli E; Barsotti G
    Biomed Pharmacother; 2003; 57(3-4):169-72. PubMed ID: 12818479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of albuminuria and its relationship with blood pressure in dogs with chronic kidney disease.
    Bacic A; Kogika MM; Barbaro KC; Iuamoto CS; Simões DM; Santoro ML
    Vet Clin Pathol; 2010 Jun; 39(2):203-9. PubMed ID: 20059754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of renal diet in association with enalapril or benazepril on proteinuria in dogs with proteinuric chronic kidney disease.
    Zatelli A; Roura X; D'Ippolito P; Berlanda M; Zini E
    Open Vet J; 2016; 6(2):121-7. PubMed ID: 27540513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.
    Sharma AM; Hollander A; Köster J; ;
    Clin Nephrol; 2005 Apr; 63(4):250-7. PubMed ID: 15847251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day-to-Day variation of the urine protein: creatinine ratio in female dogs with stable glomerular proteinuria caused by X-linked hereditary nephropathy.
    Nabity MB; Boggess MM; Kashtan CE; Lees GE
    J Vet Intern Med; 2007; 21(3):425-30. PubMed ID: 17552446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
    Wu MT; Tung SC; Hsu KT; Lee CT
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.